Drug
Hormonal Therapy Agent
Hormonal Therapy Agent is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
not_yet_recruiting250%
completed125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
NCT07032506
not_yet_recruiting
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
NCT06578169
recruiting
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
NCT06510647
completed
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
NCT05110391
Clinical Trials (4)
Showing 4 of 4 trials
NCT07032506Not Applicable
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
NCT06578169
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
NCT06510647
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
NCT05110391
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4